American Well Corporation Class A

Hello everyone and welcome to Amwell's conference call to discuss their second fiscal quarter of 2026. Joining us on the call today are Amwell's Chairman and CEO, Dr. Ido Schoenberg and Mark Hirschhorn, Amwell's CFO and Chief Operating Officer. Earlier today a press release was distributed detailing their announcement. The earnings report is posted on the Amwell website at investors.amwell.com and is also available through normal news sources. This conference call is being webcast live on the IR page of the website where replay will be archived. Before they begin prepared remarks, I'd like to take this opportunity to remind you that during the call, we will make forward-looking statements regarding projected operating results and anticipated market opportunities. This forward-looking information is subject to the risks and uncertainties described in the filings for the SEC. Actual results or events may differ materially. Except as required by law, we undertake no obligation to update or revise these forward-looking statements. On this call, we'll refer to both GAAP and non-GAAP financial measures. A reconciliation of GAAP to non-GAAP financial measures is provided in the earnings release. With that, I would now like to turn the call over to Ido.

Ido Schoenberg Good evening, and thank you for joining our second quarter earnings call. As recently announced, we reached an important milestone.

The Defense Health Agency issued an intent to award notice for a sole source contract directly with Amwell.